Uchenna G. Elemuwa

Abuja, FC, Nigeria

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Advancing the inclusion of pregnant and lactating populations in HIV PrEP research: ethical, regulatory, and surveillance recommendations from a multisectoral working group.

Advancing the inclusion of pregnant and lactating populations in HIV PrEP research: ethical, regulatory, and surveillance recommendations from a multisectoral working group.

Journal: Frontiers in public health
Published: February 14, 2026

Enhanced passive safety surveillance during the first use of the meningococcal vaccine A/C/W/Y/X conjugate for outbreak response in Niger and Nigeria.

Enhanced passive safety surveillance during the first use of the meningococcal vaccine A/C/W/Y/X conjugate for outbreak response in Niger and Nigeria.

Journal: Vaccine
Published: December 31, 2025

Correction: Safety and immunogenicity of fractional COVID-19 vaccine doses in Nigerian adults: A randomized non-inferiority trial.

Correction: Safety and immunogenicity of fractional COVID-19 vaccine doses in Nigerian adults: A randomized non-inferiority trial.

Journal: Scientific reports
Published: August 20, 2025

Safety and immunogenicity of fractional COVID-19 vaccine doses in Nigerian adults: A randomized non-inferiority trial.

Safety and immunogenicity of fractional COVID-19 vaccine doses in Nigerian adults: A randomized non-inferiority trial.

Journal: Scientific reports
Published: December 12, 2024

A triple-blinded randomized control trial to evaluate the safety and immunogenicity of fractional doses of COVID-19 vaccines (ChAd0x1, AD26.COV2. S, and BNT162B2) among Nigeria adults: the SIFCoVAN trial.

A triple-blinded randomized control trial to evaluate the safety and immunogenicity of fractional doses of COVID-19 vaccines (ChAd0x1, AD26.COV2. S, and BNT162B2) among Nigeria adults: the SIFCoVAN trial.

Journal: Trials
Published: November 16, 2024

Empowering African Expertise: Enhancing Safety Data Integration and Signal Detection for COVID-19 Vaccines Through the African Union Smart Safety Surveillance Joint Signal Management Group.

Empowering African Expertise: Enhancing Safety Data Integration and Signal Detection for COVID-19 Vaccines Through the African Union Smart Safety Surveillance Joint Signal Management Group.

Journal: Drug safety
Published: October 28, 2024

Feasibility of cohort event monitoring and assessment of reactogenicity and adverse events among a cohort of AstraZeneca and Moderna COVID-19 vaccine recipients in Nigeria, 2021.

Feasibility of cohort event monitoring and assessment of reactogenicity and adverse events among a cohort of AstraZeneca and Moderna COVID-19 vaccine recipients in Nigeria, 2021.

Journal: Vaccine
Published: April 10, 2024

Trends in Adverse Event Reporting Before and After the Introduction of the Med Safety App in Nigeria.

Trends in Adverse Event Reporting Before and After the Introduction of the Med Safety App in Nigeria.

Journal: Pharmaceutical medicine
Published: July 18, 2023

A qualitative analysis of the COVID-19 vaccination rollout in Lagos, Nigeria: Client and provider perspectives on the plan, the process and the progress.

A qualitative analysis of the COVID-19 vaccination rollout in Lagos, Nigeria: Client and provider perspectives on the plan, the process and the progress.

Journal: PLOS global public health
Published: December 23, 2021
Showing 1-9 of 9

Last Updated: 09/26/2026